Diabetes Clinical Trials in Los Angeles

Showing 61-80 of 546 trials

OP5-005 Using Omnipod 5 in Adults With Type 2

NCT05815342

This is a single arm, multi-center, prospective study that will evaluate the safety and efficacy of the Omnipod 5 Automated Insulin Delivery System in adults with type 2 diabetes requiring insulin therapy.

Type2 Diabetes

Insulet Corporation343 participantsStarted Apr 2023

Los Angeles, California, United States • Santa Barbara, California, United States • Aurora, Colorado, United States +18 more locations

COMPLETEDPhase 3< 1 mile

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

NCT06045221

The main purpose of this study is to assess efficacy and safety of orforglipron compared with oral semaglutide in participants with Type 2 diabetes and inadequate glycemic control with metformin.The study will last around 61 weeks.

Type 2 Diabetes

Eli Lilly and Company1,698 participantsStarted Sep 2023

Phoenix, Arizona, United States • Canoga Park, California, United States • Escondido, California, United States +128 more locations

OP5-005 Using Omnipod 5 in Adults With Type 2

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Diabetes Trials in Other Cities

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

Telemedicine Continuous Remote Monitoring of Adults With Uncontrolled Diabetes Mellitus

UCLA Health Patient Health Maintenance With Interactive Text Reminder

A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes

The Diabetes Prevention Program Outcomes Study AD/ADRD Project

Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec

Assess the Efficacy and Safety of Repeat Intravitreal Injections of Foselutoclax (UBX1325) in Patients With DME (ASPIRE)

A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes and Inadequate Glycemic Control With Insulin Glargine, With or Without Metformin and/or SGLT-2 Inhibitor

Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment

Denosumab for Type 1 Diabetes

A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin

A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy

Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

Study Of Drinks With Artificial Sweeteners in People With Type 2 Diabetes

Omnipod 5 System Compared to Pump Therapy

HLA Demographics Study in Adults With Type 1 Diabetes

An Efficacy, Safety, and Tolerability Study of VX-880 in Participants With Type 1 Diabetes With a Kidney Transplant

Other Conditions in Los Angeles